AstraZeneca vaccine: Blood clots are “extremely rare” and benefits outweigh risks, regulators conclude
Mechanism of abnormal movements induced by drug treatment of Parkinson’s disease
8 April 2021Oral COVID-19 vaccine being tested
8 April 2021AstraZeneca vaccine: Blood clots are “extremely rare” and benefits outweigh risks, regulators conclude
Investigations by EU and UK regulators into reports of unusual blood clots after receiving the Oxford-AstraZeneca covid-19 vaccine have concluded that these are a “possible” and “extremely rare” side…
